Aligning the Economic Value of Companion Diagnostics and Stratified Medicines

Author： Blair Edward D.   Stratton Elyse K.   Kaufmann Martina  

Publisher： MDPI

E-ISSN： 2075-4426|2|4|257-266

ISSN： 2075-4426

Source： Journal of Personalized Medicine, Vol.2, Iss.4, 2012-11, pp. : 257-266

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Beyond Genetics—Stratified and Personalised Medicines Using Multiple Parameters

By Peck Richard   Smith Patrick  

Pharmaceuticals, Vol. 3, Iss. 5, 2010-05 ,pp. : 1637-1651

MDPI

Access to resources Recommend Favorite

Australian Medicines Handbook Drug Choice Companion: Emergency and Primary Care

By  

The Australian Journal of Hospital Pharmacy, Vol. 31, Iss. 3, 2001-09 ,pp. : 237-237

John Wiley & Sons Inc

Access to resources Recommend Favorite

Value of Quantitative Photoplethysmography for Functional Vascular Diagnostics

By  

Skin Pharmacology and Physiology, Vol. 14, Iss. 5, 2001-09 ,pp. : 316-323

Karger

Access to resources Recommend Favorite

Molecular Pathology and Personalized Medicine: The Dawn of a New Era in Companion Diagnostics—Practical Considerations about Companion Diagnostics for Non-Small-Cell-Lung-Cancer

By Plönes Till   Engel-Riedel Walburga   Stoelben Erich   Limmroth Christina   Schildgen Oliver   Schildgen Verena  

Journal of Personalized Medicine, Vol. 6, Iss. 1, 2016-01 ,pp. : 3-3

MDPI

Access to resources Recommend Favorite

Understanding the Economic Value of Molecular Diagnostic Tests: Case Studies and Lessons Learned

By Towse Adrian   Ossa Diego   Veenstra David   Carlson Josh   Garrison Louis  

Journal of Personalized Medicine, Vol. 3, Iss. 4, 2013-10 ,pp. : 288-305

MDPI

Access to resources Recommend Favorite